The TSCA research and development (R&D) exemption is the provision, at Toxic Substances Control Act Section 5(h)(3) and implemented at 40 CFR 720.36, that lets a lab manufacture or import a new chemical substance — one not already on the TSCA Inventory — in small quantities for research purposes without first submitting a Premanufacture Notice (PMN) to EPA. For a university, hospital, or contract research lab that regularly synthesizes, sources, or receives small amounts of experimental compounds, this exemption is the reason most day-to-day R&D chemistry does not trigger a formal EPA new-chemical review.
It is also one of the most commonly misapplied parts of TSCA compliance, because labs often assume “this is just for research” excuses them from every other chemical-related paperwork requirement — import certification, hazard communication, waste disposal — when in fact the R&D exemption addresses one specific step (the PMN filing) and nothing else.
What the R&D Exemption Actually Covers
Under TSCA Section 5, anyone who manufactures (which includes importing) a chemical substance new to the TSCA Inventory must generally file a PMN with EPA and wait out a review period before manufacture begins. Section 5(h)(3) carves out an exemption from that PMN requirement specifically for substances manufactured or imported only in small quantities solely for research and development — scientific experimentation, analysis, or research on the chemical’s properties, performance, or production methods.
EPA’s own guidance on the exemption is explicit that no application or advance notice is required to use it: a lab does not file anything with EPA to claim R&D status. Instead, the burden sits entirely on the company or institution making the claim — it must independently be able to demonstrate, if EPA ever asks, that the activity genuinely qualifies.
What Has to Be True for the Exemption to Apply
Three conditions run through 40 CFR 720.36 and EPA’s interpretive guidance:
- Small quantity. The amount manufactured or imported has to be reasonable for the stated research purpose — not a production-scale quantity dressed up as a research order. There is no single numeric cap that applies across every substance; “reasonable for the R&D use” is judged against what the specific experimentation actually requires.
- Genuine R&D purpose. The use has to be actual scientific experimentation, analysis, or product/process research — not manufacture for eventual commercial sale dressed up as R&D.
- Recordkeeping and, where the substance leaves the lab, notice. A lab claiming the exemption should be able to produce records showing what was made or imported, in what quantity, on what date, and for what research purpose. If the substance is transferred or distributed to anyone outside the manufacturing company — a collaborator, a contract lab, a customer receiving a sample — the manufacturer has to notify the recipient that the material is for R&D use only and provide the hazard and risk information needed to handle it safely. That obligation does not go away just because money changed hands: EPA’s guidance is explicit that a company can be compensated for R&D-exempt material and the exemption still applies, as long as the R&D-only notice and hazard information travel with it.
Where the Exemption Ends
The R&D exemption tracks the R&D use, not the substance permanently. Two things end it:
- Consumer distribution is off-limits entirely. An R&D-exempt substance cannot reach consumers, regardless of quantity or labeling.
- Moving to commercial manufacture requires a PMN first. Once a lab (or the company it works with) intends to manufacture or process the substance beyond R&D purposes — scaling toward commercial production — a Section 5 Premanufacture Notice has to be filed with EPA before that commercial manufacture starts, even if R&D-scale work on the same substance continues elsewhere.
This is the point that trips up tech-transfer and industry-partnership arrangements specifically: a compound that has legitimately been R&D-exempt through years of bench research does not carry that exemption automatically into a scale-up or licensing deal. The transition itself is the regulatory trigger.
What the R&D Exemption Does Not Cover
This is the most common source of confusion, and it is worth stating plainly: the Section 5(h)(3) R&D exemption only relieves a lab of the PMN filing requirement. It does not exempt anything else.
- It does not waive TSCA import certification. A shipment of chemicals entering the US still generally requires a positive or negative TSCA certification statement at the border under Section 13, filed with US Customs and Border Protection, regardless of whether the chemical inside qualifies for the R&D exemption from PMN filing. These are two different sections of the statute doing two different jobs. See TSCA Form: How to Complete the Chemical Import Certification for how that certification actually works.
- It does not touch hazard communication, storage, or disposal obligations. A chemical brought in under the R&D exemption is still subject to OSHA’s Hazard Communication Standard, GHS labeling, and your institution’s chemical hygiene program once it’s in the building. See How to Read a Safety Data Sheet (SDS) and How to Write and Maintain a Chemical Hygiene Plan.
- It is not the only EPA new-chemical exemption. EPA also administers a separate Low Volume Exemption (LVE), at 40 CFR 723.50, for new chemicals manufactured at genuinely low annual volumes even outside pure R&D use, and a Test Marketing Exemption at 40 CFR 720.38 for limited commercial test marketing of a new chemical before a full PMN. Both require an actual application to EPA and agency approval before manufacture — unlike the R&D exemption, which requires no filing at all. Don’t conflate the three; they have different triggers, different paperwork, and different EPA involvement.
- It is unrelated to export controls. Whether a chemical, or the technology behind synthesizing it, is subject to the Export Administration Regulations or ITAR is a separate legal question from TSCA status. See Export Control (EAR/ITAR) and International Research Collaboration if your R&D chemical also has export-control implications (for example, sending a sample to a foreign collaborator).
A Practical Checklist for a Research Lab
- Confirm the substance is actually new under TSCA — check it against the TSCA Inventory. If it’s already listed, none of this applies; ordinary TSCA regulations (not Section 5 review) govern it.
- Confirm the intended use is genuine research and development, not production-scale manufacture routed through a lab order to avoid PMN review.
- Keep quantities proportionate to the actual experimental need, and keep records — quantity, date, purpose, and who handled it — under the supervision of a technically qualified person able to answer for the claim if EPA asks.
- If the substance leaves your institution to a collaborator, contractor, or customer, send written notice that it is for R&D use only, along with the hazard and risk information needed to handle it safely — this obligation applies even if the recipient pays for the material.
- Before any scale-up toward commercial manufacture or processing, stop and file a PMN (or confirm your industry partner has) — do not assume years of R&D-exempt history at bench scale carries over automatically.
- Separately, confirm whether the shipment crossing a US border needs a TSCA Section 13 import certification — that requirement runs independently of R&D status. See the TSCA import certification guide.
- Handle the substance under your institution’s normal chemical hygiene, hazard communication, and chemical inventory management program — the R&D exemption is a PMN carve-out, not a lab-safety carve-out.
Frequently Asked Questions
Does the TSCA R&D exemption apply to importing chemicals, or just manufacturing them domestically?
Both. TSCA defines “manufacture” to include import, so a lab importing a small quantity of a new chemical substance solely for R&D use can rely on the same Section 5(h)(3) exemption from PMN filing that applies to domestic synthesis.
Do I need to notify EPA or file anything to use the R&D exemption?
No. EPA’s guidance is explicit that no application is required to claim the R&D exemption under Section 5(h)(3) — unlike the Low Volume Exemption or Test Marketing Exemption, which do require an application and EPA sign-off before manufacture. The tradeoff is that the burden of proving the claim is legitimate sits entirely with the institution claiming it.
Does using the R&D exemption mean I don’t need a TSCA import certification at the border?
No. That’s the single most common mix-up. The Section 5(h)(3) R&D exemption relieves the PMN filing obligation; the Section 13 import certification, filed with US Customs and Border Protection at the time of entry, is a separate requirement that generally still applies to the shipment regardless of R&D status. Confirm with your customs broker or compliance office rather than assuming R&D use exempts a shipment from certification.
What counts as a “small quantity” under the exemption?
There’s no single fixed number in the regulation. EPA and the courts have consistently read “small quantity solely for research and development” as tied to what the specific experimentation actually requires — a quantity large enough to look like disguised commercial-scale production, even if labeled “R&D,” would not qualify.
What happens if I want to move an R&D-exempt chemical toward commercial production?
You (or your industry partner) need to file a Premanufacture Notice with EPA before commercial-scale manufacture or processing begins. The R&D exemption does not carry forward into commercial manufacture just because the substance was legitimately R&D-exempt at bench scale.
